09966 康寧傑瑞製藥－Ｂ
按盘价 
3.750 -0.080 (-2.089%) 盈利能力分析
| 2023/12 | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| 资产回报率 (%) | -9.899% | -13.508% | -15.433% | -15.572% | -45.239% |
| 股东资金回报率 (%) | -13.041% | -19.004% | -19.907% | -18.207% | -77.145% |
| 资本运用回报率 (%) | -11.260% | -18.799% | -19.944% | -18.518% | -31.376% |
边际利润分析
| 2023/12 | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| 毛利率 (%) | 74.752% | 73.504% | 97.926% | N/A | N/A |
| 未计利息、税项、折旧及摊销前利润率 (%) | -92.944% | -173.930% | -264.304% | N/A | N/A |
| 税前边际利润率 (%) | -96.261% | -195.224% | -282.437% | N/A | N/A |
| 纯利率 (%) | -96.261% | -195.224% | -282.437% | N/A | N/A |
变现能力分析
| 2023/12 | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| 流动比率 (X) | 5.841 X | 3.883 X | 3.321 X | 6.674 X | 12.190 X |
| 速动比率 (X) | 5.546 X | 3.715 X | 3.230 X | 6.539 X | 12.061 X |
财务杠杆分析
| 2023/12 | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| 总负债 / 总资产比率 (%) | 21.758% | 26.439% | 30.860% | 13.883% | 15.016% |
| 总债项 / 总资产比率 (%) | 12.029% | 16.311% | 23.558% | 8.441% | 8.869% |
| 净债项 / 总资产比率 (%) | -38.786% | -34.181% | -6.138% | 1.420% | -56.565% |
| 总债项 / 股东资金比率 (%) | 15.375% | 22.174% | 34.073% | 9.802% | 10.436% |
| 长期债项 / 股东资金比率 (%) | 10.560% | 9.969% | 9.274% | 1.085% | 8.712% |
| 净债项 / 股东资金比率 (%) | -49.573% | -46.467% | -8.878% | 1.649% | -66.560% |
| 净现金 / (债项) ($) | 8.29亿 | 7.24亿 | 1.66亿 | (3.75千万) | 16.15亿 |
| 每股净现金 / (债项) ($) | 0.859 | 0.770 | 0.177 | (0.040) | 1.800 |
| 总债项 / 资本运用比率 (%) | 13.746% | 19.935% | 30.818% | 9.645% | 9.539% |
| 利息盈利率 (X) | N/A | N/A | N/A | N/A | N/A |
营运效率分析
| 2023/12 | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| 存货周转率日数 (日) | 473.730日 | 505.899日 | 6161.424日 | -- | -- |
| 应收贸易帐周转率日数 (日) | 18.870日 | 25.263日 | 19.012日 | N/A | N/A |
| 应付贸易帐周转率日数 (日) | 33.596日 | 26.848日 | 16.180日 | N/A | N/A |
| 备注： | 实时报价更新时间为31/10/2024 17:59 |
| 港股实时基本市场行情由香港交易所提供; 香港交易所指定免费发放实时基本市场行情的网站。 | |
| 股东应占溢利/(亏损) () | RMB -44,896,000 |
| 增长率 | 12.629% |
| 每股盈利/(亏损) | RMB -0.050 |
| 每股账面资产净值 (¥) | RMB 1.688 |